20328 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles
Amidine derivatives for treating amyloidosis
#1802Ubiquitin ligase inhibitors and methods related thereto
#1803Nonsedating α-2 agonists
#1804Method for treatment or prevention of androgen deficiency
#1805MAG expression promoters
#1806Compounds, formulations, and methods for ameliorating telangiectasias
#1807Benzimidazolidinone derivatives as muscarinic agents
#1808Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
#1809Composition and method for treating nosebleeds
#1810Method of improved drug delivery and for treatment of cellulitis
#1811Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
#1812Methods for manipulating satiety
#1813Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist
#1814Methods of treating cognitive dysfunction by modulating brain energy metabolism
#1815Pharmaceutical composition
#1816Effervescent compositions comprising bisphosphonates and methods related thereto
#1817Irrigation solution and method for inhibition of pain and inflammation
#1818Pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
#1819Modulation of Microglial by Nicotinic Medications
#1820Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
#1821Combination product comprising an antagonist or inverse agonist of histamine receptor H and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs
#1822Compositions and methods for systemic inhibition of cartilage degradation
#1823Benzimidazolidinone derivatives as muscarinic agents
#1824Irrigation solution and method for inhibition of pain and inflammation
#1825Irrigation solution and method for inhibition of pain and inflammation
#1826Use of ALK 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals
#1827Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#1828Topical oral care compositions comprising host response modulating agents
#1829Combination of gh secret agogues and pde4 inhibitors for the treatment of alzheimers disease
#1830Metronidazole-based tinted topical pharmaceutical compositions
#1831Agent for preventing or treating portal hypertension
#1832Method for treating bruxism and bruxism-related diseases
#1833Functionalized drugs and polymers derived therefrom
#1834Compositions and methods for the treatment of arthritis
#1835Compounds, formulations, and methods for treating or preventing rosacea
#1836Oral pharmaceutical forms of liquid drugs having improved bioavailability
#18375-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism
#1838Agent for prophylaxis and treatment of diabetic complications
#18392-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
#1840Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
#1841Combinations for the treatment of rheumatoid arithritis
#1842Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#1843Cosmetic and pharmaceutical foam
#1844Formulations containing substituted imidazole derivatives
#1845Controlled release composition
#1846Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells
#1847Formulations of substituted benzoxazoles
#1848Formulations of substituted benzoxazoles
#1849Formulations of substituted benzoxazoles
#1850Gastric acid secretion inhibiting composition
#1851Therapeutic agent for steroid depending-and/or steroid resistant- ulcerative colitis
#1852Inhibitors against the activation of ap-1 and nfat
#1853Intravaginal treatment of vaginal infections with metronidazole compositions
#1854Nf-kb activation inhibitors
#1855Stabilized A-beta protofibrillar aggregates
#1856Imidazole derivatives modulating the sodium channels
#1857Combination of an aromatase inhibitor with a bisphosphonate
#1858Methods for the amelioration of episodes of acute or chronic ulcerative colitis
#1859Treatment of dependence and dependence related withdrawal symptoms
#1860Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin II receptor blocker
#1861Oromucosal formulation and process for preparing the same
#1862Neurological functions
#1863Method of treatment of gastroesophageal reflux disease and laryngopharyngeal reflux disease
#1864Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
#1865Remedies for neurodegenerative diseases
#1866Methods of treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
#1867Foamable compositions containing nitro-imidazoles, processes for preparing same and methods of treatment utilizing same
#1868Treatment of rheumatoid arthritis by inhibition of pde4
#1869Antimicrobial mesoporous silica nanoparticles
#1870Medicament for treatment of cancer
#1871Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
#1872Compositions and methods for topical administration of 2-NH-heteroarylimidazoles
#1873Diphenyl ether derivatives
#1874Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
#1875Body cavity foams
#1876Combinatorial methods and compositions for treatment of melanoma
#1877β2-adrenergic receptor agonists
#1878Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
#1879Nitric oxide scavengers
#1880Treatment of dyskinesia
#1881Iron binding agents
#1882Treatments for viral infections
#1883Method for prophylaxis and treatment of diabetic complications with 4{alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl}-3,5-dimethylbenzoic acid and derivatives
#1884Compositions and methods for topical diagnostic and therapeutic transport
#1885Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
#1886Use of edg-receptor agonists for the treatment of hypertension
#1887Beta secretase inhibitors
#1888Chain oligolactic acid thioester
#1889Compositions and methods of treating infections
#1890Active substance combination
#1891Active substance combination
#1892Inhibitors of glutaminyl cyclase
#1893Method to inhibit ischemia and reperfusion injury
#1894Modafinil combination therapy for improving sleep quality
#1895Percutaneous absorption promoters and compositions for treating athlete's foot
#1896Ion channel modulators
#1897Compounds as opioid receptor modulators
#1898Antagonists for treatment of CD/11CD18 adhesion receptor mediated disorders
#1899Methods of treatment using an EP2 selective receptor agonist
#1900Inhibitors of dipeptidylpeptidase IV
#1901Liquid pharmaceutical composition
#1902Liquid pharmaceutical composition
#1903Antifungal and/or antimycotic external preparation for nail
#1904Kit and composition of imidazole with enhanced bioavailability
#1905Transdermal penetration system and treatment for cellulite
#1906Inactivated probiotic bacteria and methods of use thereof
#1907Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
#1908Method for treatment of reactive arthritis or bursitis
#1909Peptides as NS3-serine protease inhibitors of hepatitis C virus
#1910Pharmaceutically active aromatic guanylhydrazones
#1911Method of treatment or prevention of obesity
#1912Combinations useful for the treatment of neuronal disorders
#1913Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#1914Histone deacetylase inhibitors
#1915Method of treatment of otitis externa
#1916Pharmaceutical composition consisting of a beta-3-adrenoceptor agonist and alpha-agonist
#1917Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease
#1918Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase
#1919Formulation for treating periocular disease
#1920Method for treatment of reactive arthritis or bursitis
#1921Combinations useful for the treatment of neuronal disorders
#1922Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
#1923Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
#1924Remedies and/or preventives for diabetic ischemic heart diseases
#1925Aqueous compositions containing metronidazole
#1926Derivatives of azaspiro compounds for the treatment of pain
#1927Combinations and methods for treating neoplasms
#1928Methods for treating congestive heart failure
#1929Methods of treating conditions associated with an EDG-4 receptor
#1930Process for the purification of climbazole
#1931Use of selective CB1-antagonists in medical treatments
#1932Methods of treating conditions associated with an EDG-2 receptor
#1933MAG expression promoters
#1934Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
#1935Ophthalmic formulations including selective alpha 1 antagonists
#1936Vaginal pharmaceutical compositions and methods for preparing them
#1937Nonsedating α-2 agonists
#1938Novel methods for identifying improved, non-sedating alpha-2 agonists
#1939Treatment for reactive arthritis or bursitis
#1940Azole derivatives and pharmaceutical compositions containing them
#1941Non-nucleoside reverse transcriptase inhibitors
#1942Partially absorbable fiber-reinforced composites for controlled drug delivery
#1943Anti-glycation agents for preventing age- diabetes- and smoking-related complications
#1944Method of treatment of otitis externa
#1945Method for treatment of cancer and compositions for use therein
#1946Immune activation by double-stranded polynucleotides
#1947Non-psychotropic cannabinoids
#1948Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
#1949Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
#1950Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds
#1951Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
#1952Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#1953Method for treating perinatal asphyxia in a human or animal neonate
#1954Method of diagnosing fibromyalgia caused by small intestinal bacterial overgrowth
#1955Methods and compositions for treating hemorrhoids
#19562-aminomethylimidazole mimics of NS4A and their effect thereof on hepatitis C virus NS3 protease
#19574,5-bis(4-chlorophenyl)-2-phenyl-1H-imidazol-1-yl as an antimicrobial compound
#19582-(4-chlorophenyl)-4,5-bis(4-chlorophenyl)-1H-imidazole as an antimicrobial compound
#1959Treatment of glioblastoma
#1960Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#1961TEAD inhibitors and uses thereof
#1962Compositions and methods for treating ocular disorders
#1963Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#1964Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#1965Single solid oral dosage forms for treating infection and duodenal ulcer disease
#1966Pristinamycin compositions, LPXC compositions, their improvements, and combinations thereof
#1967Compositions and methods for treatment of Bowen's disease and related diseases
#1968Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
#1969Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#1970Therapeutic compositions comprising imidazole and imidazolium compounds
#1971Therapeutic compositions comprising imidazole and imidazolium compounds
#1972Methods of colchicine administration
#1973Synergistic microbicidal combinations